Long-term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight®) in previously treated patients with severe haemophilia A: Interim results of the guardian™2 extension trial

M. Ozelo, M. Misgav, F. Abdul Karim, S. R. Lentz, M. Martin-Salces, I. Matytsina, T. Saugstrup, E. Santagostino

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e436-e439
JournalHaemophilia
Volume21
Issue number5
DOIs
Publication statusPublished - Sep 1 2015

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)

Cite this